TARA COONEY: Open Payments
NPI 1770212615 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,045 in 119 payments from 16 companies in 2025. Trend: 2023 $1,678 · 2024 $3,030 · 2025 $2,045
Food & beverage: $2,035Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $631 |
| Madrigal Pharmaceuticals | 10 | $207 |
| Janssen Biotech, Inc. | 14 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $167 |
| Ardelyx, Inc. | 11 | $152 |
| GENZYME CORPORATION | 6 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $135 |
| QOL Medical, LLC | 5 | $100 |
| Phathom Pharmaceuticals, Inc. | 6 | $86 |
| Gilead Sciences, Inc. | 4 | $68 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, ENTYVIO, DUPIXENT, IBSRELA, MAVYRET, XIFAXAN.
Industry payments across PA — which companies pay providers there.
